LGALS3 and cancer: Among the molecular mechanisms accounting for the powerful lymphocyte inhibitory effect of Gal-3 in cancers, this protein modulates the interactions between T cells and antigen-presenting cells, thus, playing a central role in the initial steps of tumor antigen presentation [100].